Assets, Current of SINOVAC BIOTECH LTD from 31 Dec 2010 to 31 Dec 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
- Summary
-
SINOVAC BIOTECH LTD quarterly Assets, Current in USD history and change rate from 31 Dec 2010 to 31 Dec 2023.
- SINOVAC BIOTECH LTD Assets, Current for the quarter ending 31 Dec 2023 was $11,830,556,000, a 2.4% decline year-over-year.
- Source SEC data
- View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)
SINOVAC BIOTECH LTD Quarterly Assets, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | $11,830,556,000 | -$295,840,000 | -2.4% | 31 Dec 2023 | 20-F | 29 Apr 2024 | 2023 | FY |
| Q4 2022 | $12,126,396,000 | -$2,788,713,000 | -19% | 31 Dec 2022 | 20-F | 29 Apr 2024 | 2023 | FY |
| Q4 2021 | $14,915,109,000 | +$13,354,816,000 | +856% | 31 Dec 2021 | 20-F | 01 May 2023 | 2022 | FY |
| Q4 2020 | $1,560,293,000 | +$1,210,686,000 | +346% | 31 Dec 2020 | 20-F | 29 Apr 2022 | 2021 | FY |
| Q4 2019 | $349,607,000 | +$65,432,000 | +23% | 31 Dec 2019 | 20-F | 22 Apr 2021 | 2020 | FY |
| Q4 2018 | $284,175,000 | +$80,287,000 | +39% | 31 Dec 2018 | 20-F | 30 Apr 2020 | 2019 | FY |
| Q4 2017 | $203,888,000 | +$73,141,000 | +56% | 31 Dec 2017 | 20-F | 29 Apr 2019 | 2018 | FY |
| Q4 2016 | $130,747,000 | +$2,253,000 | +1.8% | 31 Dec 2016 | 20-F | 11 May 2018 | 2017 | FY |
| Q4 2015 | $128,494,000 | -$26,309,000 | -17% | 31 Dec 2015 | 20-F | 22 Nov 2017 | 2016 | FY |
| Q4 2014 | $154,803,000 | -$2,447,000 | -1.6% | 31 Dec 2014 | 20-F | 25 Apr 2016 | 2015 | FY |
| Q4 2013 | $157,250,000 | +$30,967,000 | +25% | 31 Dec 2013 | 20-F | 29 Apr 2015 | 2014 | FY |
| Q4 2012 | $126,283,000 | -$5,756,085 | -4.4% | 31 Dec 2012 | 20-F | 16 Apr 2014 | 2013 | FY |
| Q4 2011 | $132,039,085 | -$14,937,480 | -10% | 31 Dec 2011 | 20-F/A | 23 May 2013 | 2012 | FY |
| Q4 2010 | $146,976,565 | 31 Dec 2010 | 20-F | 12 Apr 2012 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.